Pfizer Inc. Files Proxy Materials
Ticker: PFE · Form: DEFA14A · Filed: Apr 11, 2025 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | DEFA14A |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy, shareholder-meeting
Related Tickers: PFE
TL;DR
Pfizer filed proxy docs, vote your shares!
AI Summary
Pfizer Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on April 11, 2025. The filing is related to the company's solicitation of proxies for its upcoming shareholder meeting. The document indicates that no filing fee was required, or it was previously paid.
Why It Matters
This filing is a standard procedural step for public companies to communicate with shareholders regarding voting matters, ensuring transparency and shareholder participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate actions that would inherently increase risk.
Key Players & Entities
- Pfizer Inc. (company) — Registrant
- Margaret M. Madden (person) — Contact Person
FAQ
What type of filing is this DEFA14A for Pfizer Inc.?
This is a Definitive Additional Materials proxy statement filed by Pfizer Inc.
When was this filing submitted to the SEC?
The filing was submitted on April 11, 2025.
What is Pfizer Inc.'s business address?
Pfizer Inc.'s business address is 66 Hudson Boulevard East, New York, NY 10001-2192.
Does this filing require a fee?
The filing indicates 'No fee required' or that the fee was paid previously with preliminary materials.
Who is listed as a contact person for this filing?
Margaret M. Madden is listed as a contact person for this filing.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 11, 2025 by Margaret M. Madden regarding PFIZER INC (PFE).